Trial intelligence / Profile preview

Phase IIa crossover trial of inhaled LAS100977 in asthma

2007-003415-31Phase 2Completed

Sponsor
Almirall
Start
Feb 2008
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial of abediterol in asthma (3 arms), sponsored by Almirall. Primary endpoint: Spirometry endpoints. Started Feb 2008; status: completed.

02

Drugs

abediterol
03

Conditions

asthma

Beyond the preview

Go deeper on 2007-003415-31.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2007-003415-31.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call